Bionic Pancreas
Sponsors
Massachusetts General Hospital, University of Colorado, Denver
Conditions
Autoimmune DiabetesCystic Fibrosis-related DiabetesDiabetesDiabetes MellitusDiabetes Mellitus Type 1Diabetes Mellitus Type 2Diabetes Mellitus Type IIDiabetes Mellitus, Brittle
Phase 2
Unknown Phase
A Multicenter Study of Outpatient Automated Blood Glucose Control With a Bihormonal Bionic Pancreas
CompletedNCT02092220
Start: 2014-04-30End: 2016-12-31Updated: 2017-11-22
The Summer Camp Study 2: Blood Glucose Control With a Bi-Hormonal Endocrine Pancreas
CompletedNCT02105324
Start: 2014-06-30End: 2014-08-31Updated: 2017-10-20
The Set-Point Study: Evaluating Effects of Changing Glucose Target on Bionic Pancreas Performance
CompletedNCT02509065
Start: 2015-08-31End: 2017-12-31Updated: 2018-11-20
Feasibility of Outpatient Closed Loop Control With the iLet Bionic Pancreas in Cystic Fibrosis Related Diabetes
CompletedNCT03258853
Start: 2021-08-26End: 2022-06-29Updated: 2023-07-20
The Set-Point Study for Type 2 Diabetes: Evaluating the Use of an Insulin Only Bionic Pancreas System in Type 2 Diabetes
CompletedNCT03552523
Start: 2017-07-28End: 2018-03-29Updated: 2019-09-10
Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth
CompletedNCT05168657
Start: 2022-03-31End: 2023-05-23Updated: 2024-10-21
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
RecruitingNCT07011147
Start: 2026-01-16End: 2029-04-01Target: 240Updated: 2026-04-02